To develop COVID-19 countermeasures, powerful research tools are essential. We produced a SARS-COV-2 reverse genetic (RG) infectious clone toolkit that will benefit a variety of investigations. ABSTRACT Newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has caused extensive mortality and morbidity and wreaked havoc on socioeconomic structures. The urgent need to better understand SARS-CoV-2 biology and enable continued development of effective countermeasures is aided by the production of laboratory tools that facilitate SARS-CoV-2 research. We previously created a directly accessible SARS-CoV-2 toolkit containing user-friendly reverse genetic (RG) infectious clones of SARS-CoV-2. Here, using K18-human ACE2 (hACE2) mice, we confirmed the validity of RG-rescued SARS-CoV-2 viruses to reproduce the infection profile, clinical disease, and pathogenesis already established in mice infected with natural SARS-CoV-2 isolates, often patient derived. RG-rescued SARS-CoV-2-infected K18-hACE2 mice developed substantial clinical disease and weight loss by day 6 postinfection. RG-rescued SARS-CoV-2 was recovered from the lungs and brains of infected K18-hACE2 mice, and infection resulted in viral pneumonia with considerable changes in lung pathology, as seen previously with natural SARS-CoV-2 infection. In mice infected with RG-rescued SARS-CoV-2-mCherry, mCherry was detected in areas of lung consolidation and colocalized with clinically relevant SARS-CoV-2-assocated immunopathology. RG-rescued SARS-CoV-2 viruses successfully recapitulated many of the features of severe COVID-19 associated with the K18-hACE2 model of SARS-CoV-2 infection. With utility in vivo , the RG-rescued SARS-CoV-2 viruses will be valuable resources to advance numerous areas of SARS-CoV-2 basic research and COVID-19 vaccine development.
【저자키워드】 coronavirus, Cytokines, Lung infection, respiratory viruses, infectious clones, 【초록키워드】 COVID-19, coronavirus disease, viruses, SARS-CoV-2, Coronavirus disease 2019, ACE2, coronavirus, pandemic, Pathogenesis, Mortality, severe COVID-19, Pneumonia, SARS-COV-2 infection, Genetic, Infection, lung, immunopathology, severe acute respiratory syndrome Coronavirus, Brain, hACE2, Laboratory, human ACE2, Viral pneumonia, Viral, mice, Lungs, morbidity, Research, Patient, Validity, K18-hACE2 mice, respiratory, in vivo, utility, consolidation, K18-hACE2, Lung pathology, structures, causative agent, weight loss, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, COVID-19 vaccine development, SARS-CoV-2 research, SARS-CoV-2 biology, toolkit, SARS-CoV-2 isolates, clinical disease, valuable resource, clone, brains, mCherry, RG-rescued SARS-CoV-2 viruses, SARS-CoV-2 toolkit, feature, effective, benefit, Postinfection, produced, develop, caused, clinically, facilitate, changes in, in viral, variety, RG-rescued SARS-CoV-2 virus, SARS-CoV-2-mCherry, 【제목키워드】 SARS-CoV-2, ACE2, pulmonary, cause, Produce,